3 terminated, 1 recruiting, 1 unknown. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 3, Recruiting 1, Unknown 1 |
| Phase 1 | 3 | Terminated 3 |
Follow Congenital Microtia: new trials by email Literature Review of Congenital Microtia trials Research Report on Congenital Microtia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice Vivomixx®, Placebo - Neonatal Jaundice, Microtia | Phase 2 | Unknown | Chinese University of Hong Kong | 94 | 2024-03-23 | 2024-05-20 |
| Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201 AUR-201 - Microtia | Phase 1 / Phase 2 | Terminated | Auregen Biotherapeutics, SA | 1 | 2024-01-26 | 2025-11-21 |
| Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia AUR-201 - Microtia | Phase 1 / Phase 2 | Terminated | Auregen Biotherapeutics, SA | 3 | 2024-01-26 | 2025-11-21 |
| Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT Probiotic, Placebo - Microtia, Dysbiosis | Phase 2 | Recruiting | Vanderbilt University Medical Center | 250 | 2023-09-18 | 2026-08-27 |
| AuriNovo for Auricular Reconstruction AuriNovo - Microtia | Phase 1 / Phase 2 | Terminated | 3DBio Therapeutics | 2 | 2021-08-09 | 2024-03-04 |
Alcohol Drinking (1) · Cardiovascular Diseases (1) · Dysbiosis (1) · HIV Infections (1) · Hyperbilirubinemia, Neonatal (1) · Jaundice, Neonatal (1)
Congenital Abnormalities (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Ear Diseases (5) · Otorhinolaryngologic Diseases (5) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Behavior (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Drinking Behavior (1) · Genital Diseases (1) · Hyperbilirubinemia (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infant, Newborn, Diseases (1)
Probiotics (1)
Auregen Biotherapeutics, SA (2) · 3DBio Therapeutics (1) · Chinese University of Hong Kong (1) · Vanderbilt University Medical Center (1)
United States (4) · Hong Kong (1)
Thomas Romo, III, MD, FACS (2) · Chi C Wang, Professor (1)